HER2 expression in urothelial carcinoma, a systematic literature review

BACKGROUND: Urothelial carcinoma (UC) is a common malignancy with significant associated mortality. Recent clinical trials suggest an emerging role for HER2-targeted therapy. Testing for HER2 expression in UC is not part of current routine clinical practice. In consequence, the prevalence of HER2 ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherrer, Emilie, Kang, Ashley, Bloudek, Lisa M., Koshkin, Vadim S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635895/
https://www.ncbi.nlm.nih.gov/pubmed/36338710
http://dx.doi.org/10.3389/fonc.2022.1011885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635895/
https://www.ncbi.nlm.nih.gov/pubmed/36338710
http://dx.doi.org/10.3389/fonc.2022.1011885

Ejemplares similares